Mackenzie Financial Corp Axogen, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 15, 2018	SELL	$34.05 - $55.9 $499,002 - $819,214	-14,655 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$36.15 - $52.5 $32,535 - $47,250	900 Added 6.54%	14,655 $736,000
Q1 2018 May 14, 2018	BUY	$24.4 - $40.25 $335,622 - $553,638	13,755 New	13,755 $502,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $688M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.